Related references
Note: Only part of the references are listed.Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study
Matthew Kang et al.
BLOOD (2015)
De novo synthesis of a narrow size distribution low-molecular-weight heparin
Kasemsiri Chandarajoti et al.
GLYCOBIOLOGY (2014)
Chemoenzymatic synthesis of heparan sulfate and heparin
Jian Liu et al.
NATURAL PRODUCT REPORTS (2014)
Homogeneous low-molecular-weight heparins with reversible anticoagulant activity
Yongmei Xu et al.
NATURE CHEMICAL BIOLOGY (2014)
Use of biosynthetic enzymes in heparin and heparan sulfate synthesis
Elizabeth P. Chappell et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Interplay between coagulation and vascular inflammation in sickle cell disease
Erica Sparkenbaugh et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
First Gram-Scale Synthesis of a Heparin-Related Dodecasaccharide
Steen U. Hansen et al.
ORGANIC LETTERS (2013)
Tetrasaccharide iteration synthesis of a heparin-like dodecasaccharide and radiolabelling for in vivo tissue distribution studies
Steen U. Hansen et al.
NATURE COMMUNICATIONS (2013)
Parenteral Anticoagulants Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
David A. Garcia et al.
CHEST (2012)
Synthetic heparin
Robert J. Linhardt et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Chemoenzymatic Synthesis of Heparin Oligosaccharides with both Anti-factor Xa and Anti-factor IIa Activities
Yongmei Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Probing Structural Selectivity of Synthetic Heparin Binding to Stabilin Protein Receptors
Elizabeth H. Pempe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Chemoenzymatic Synthesis of Uridine Diphosphate-GlcNAc and Uridine Diphosphate-GalNAc Analogs for the Preparation of Unnatural Glycosaminoglycans
Sayaka Masuko et al.
JOURNAL OF ORGANIC CHEMISTRY (2012)
Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparin
Andrea F. Moon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Protamine reversal of low molecular weight heparin: clinically effective?
Joost J. van Veen et al.
BLOOD COAGULATION & FIBRINOLYSIS (2011)
Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3'-phosphoadenosine-5'-phosphosulfate
Xianxuan Zhou et al.
GLYCOBIOLOGY (2011)
The Dominating Role of N-Deacetylase/N-Sulfotransferase 1 in Forming Domain Structures in Heparan Sulfate
Juzheng Sheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight Heparins
Yongmei Xu et al.
SCIENCE (2011)
Heparan Sulfate Proteoglycans
Stephane Sarrazin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
In vitro synthesis of heparosan using recombinant Pasteurella multocida heparosan synthase PmHS2
Anais A. E. Chavaroche et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2010)
Chemoenzymatic Design of Heparan Sulfate Oligosaccharides
Renpeng Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Design of biologically active heparan sulfate and heparin using an enzyme-based approach
Sherket Peterson et al.
NATURAL PRODUCT REPORTS (2009)
Lessons learned from the contamination of heparin
Haiying Liu et al.
NATURAL PRODUCT REPORTS (2009)
Liver sinusoidal endothelial cells are the principal site for elimination of unfractionated heparin from the circulation
Cristina Ionica Oie et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Heparin-induced thrombocytopenia: a historical perspective
John G. Kelton et al.
BLOOD (2008)
The Structure of Glycosaminoglycans and their Interactions with Proteins
Neha S. Gandhi et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2008)
The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin
Edward N. Harris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Oversulfated chondroitin sulfate: Impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation
Zhenqing Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events
Marco Guerrini et al.
NATURE BIOTECHNOLOGY (2008)
Outbreak of Adverse Reactions Associated with Contaminated Heparin
David B. Blossom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Contaminated heparin associated with adverse clinical events and activation of the contact system
Takashi Kei Kishimoto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Redirecting the substrate specificity of heparan sulfate 2-O-sulfotransferase by structurally guided mutagenesis
Heather N. Bethea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Chemoenzymatic synthesis with distinct Pasteurella heparosan synthases -: Monodisperse polymers and unnatural structures
Alison E. Sismey-Ragatz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures
Jinghua Chen et al.
CHEMISTRY & BIOLOGY (2007)
Beyond unfractionated heparin and warfarin - Current and future advances
Jack Hirsh et al.
CIRCULATION (2007)
Heparan sulphate proteoglycans fine-tune mammalian physiology
Joseph R. Bishop et al.
NATURE (2007)
Molecular weight dependent tissue factor pathway inhibitor release by heparin and heparin oligosaccharides
Qing Ma et al.
THROMBOSIS RESEARCH (2007)
Determination of the substrate specificities of N-acetyl-D-glucosaminyltransferase
Miao Chen et al.
BIOCHEMISTRY (2006)
Meta-analysis: Low-molecular-weight heparin and bleeding in patients with severe renal insufficiency
W Lim et al.
ANNALS OF INTERNAL MEDICINE (2006)
Risk for heparin-induced thrombocytopenia. with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
N Martel et al.
BLOOD (2005)
Incomplete reversal of enoxaparin toxicity by protamine: Implications of renal insufficiency, obesity, and low molecular weight heparin sulfate content
LS Chawla et al.
OBESITY SURGERY (2004)
Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism - A meta-analysis of randomized, controlled trials
DJ Quinlan et al.
ANNALS OF INTERNAL MEDICINE (2004)
Heparin and low-molecular-weight heparin - The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
J Hirsh et al.
CHEST (2004)
A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?
M Petitou et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
Substrate specificity of the heparan sulfate hexuronic acid 2-O-sulfotransferase
JH Rong et al.
BIOCHEMISTRY (2001)
Specificities of heparan sulphate proteoglycans in developmental processes
N Perrimon et al.
NATURE (2000)
The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine
H Habuchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
